This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Siegel RL, Miller KD, Fuchs HE, et al. Cancer statistics. CA Cancer J Clin. 2022;72(1):7–33.SiegelRLMillerKDFuchsHECancer statistics2022721733Search in Google Scholar
Cancer 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer.Available from: https://www.who.int/news-room/fact-sheets/detail/cancer.Search in Google Scholar
da Silva GBRF, Silva TGA, Duarte RA, et al. Expression of the classical and nonclassical HLA molecules in breast cancer. Int J Breast Cancer. 2013;1–9.da SilvaGBRFSilvaTGADuarteRAExpression of the classical and nonclassical HLA molecules in breast cancer201319Search in Google Scholar
Seliger B, Kloor M, Ferrone S. HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance. Oncoimmunology. 2017;6(2):1–10.SeligerBKloorMFerroneS.HLA class II antigen-processing pathway in tumors: Molecular defects and clinical relevance201762110Search in Google Scholar
Niranjana AN, Gonzalez F. Non-classical MHC class Ib-restricted cytotoxic T cells monitor antigen processing in the endoplasmic reticulum. Nat Immunol. 2012;13(6):579–586.NiranjanaANGonzalezF.Non-classical MHC class Ib-restricted cytotoxic T cells monitor antigen processing in the endoplasmic reticulum2012136579586Search in Google Scholar
Bukur J, Jasinski S, Seliger B. The role of classical and non-classical HLA class I antigens in human tumors. Semin Cancer Biol. 2012;22(4):350–358.BukurJJasinskiSSeligerB.The role of classical and non-classical HLA class I antigens in human tumors2012224350358Search in Google Scholar
Adams EJ, Luoma AM. The adaptable major histocompatibility complex (MHC) fold: Structure and function of nonclassical and mhc class I-like molecules. Annual Review of Immunology. 2013; 31:529–561.AdamsEJLuomaAM.The adaptable major histocompatibility complex (MHC) fold: Structure and function of nonclassical and mhc class I-like molecules201331529561Search in Google Scholar
Robinson J, Barker DJ, Georgiou X, et al. IPD-IMGT/HLA Database. Nucleic Acids Res. 2020; 48(D1):948–955.RobinsonJBarkerDJGeorgiouXIPD-IMGT/HLA Database202048D1948955Search in Google Scholar
Morandi F, Pistoia V. Interactions between HLA-G and HLA-E in physiological and pathological conditions. Front Immunol. 2014;5:1–6.MorandiFPistoiaV.Interactions between HLA-G and HLA-E in physiological and pathological conditions2014516Search in Google Scholar
Tronik-Le Roux D, Renard J, Vérine J, et al. Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients. Molecular Oncology. 2017;11:561–578.Tronik-Le RouxDRenardJVérineJNovel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients201711561578Search in Google Scholar
Zhang Y, Yu S, Han Y. Human leucocyte antigen-G expression and polymorphisms promote cancer development and guide cancer diagnosis/treatment. Oncol Lett. 2018;15:699–709.ZhangYYuSHanY.Human leucocyte antigen-G expression and polymorphisms promote cancer development and guide cancer diagnosis/treatment201815699709Search in Google Scholar
Campoli M, Ferrone S. HLA antigen and NK cell activating ligand expression in malignant cells: A story of loss or acquisition. Semin Immunopathol. 2011;33:321–334.CampoliMFerroneS.HLA antigen and NK cell activating ligand expression in malignant cells: A story of loss or acquisition201133321334Search in Google Scholar
Reimers MS, Engels CC, Putter H, et al. Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: A retrospective cohort study. BMC Cancer. 2014;14(1):1–12.ReimersMSEngelsCCPutterHPrognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: A retrospective cohort study2014141112Search in Google Scholar
Borst L, van der Burg SH, van Hall T. The NKG2A-HLA-E axis as a novel checkpoint in the tumor microenvironment. Clin Cancer Res. 2021;26(21):5549–5556.BorstLvan der BurgSHvan HallT.The NKG2A-HLA-E axis as a novel checkpoint in the tumor microenvironment2021262155495556Search in Google Scholar
Kamiya T, Seow SV, Wong D. Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells. J Clin Invest. 2019;129(5):2094–2106.KamiyaTSeowSVWongD.Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells2019129520942106Search in Google Scholar
Wagner B, da Silva Nardi F, Schramm S, et al. HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemia. Cancer. 2017;123(5):814–823.WagnerBda Silva NardiFSchrammSHLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemia20171235814823Search in Google Scholar
Lin A, Yan WH. The emerging roles of human leukocyte antigen-F in immune modulation and viral infection. Front Immunol. 2019;10:1–7.LinAYanWH.The emerging roles of human leukocyte antigen-F in immune modulation and viral infection20191017Search in Google Scholar
Lin A, Zhang X, Ruan YY, et al. HLA-F expression is a prognostic factor in patients with non-small-cell lung cancer. Lung Cancer. 2011;74(3):504–509.LinAZhangXRuanYYHLA-F expression is a prognostic factor in patients with non-small-cell lung cancer2011743504509Search in Google Scholar
Loustau M, Anna F, Dréan R, et al. HLA-G neo-expression on tumors. Front Immunol. 2020;11:1–15.LoustauMAnnaFDréanRHLA-G neo-expression on tumors202011115Search in Google Scholar
Lin A, Yan WH. Human leukocyte antigen-G (HLA-G) expression in cancers: Roles in immune evasion, metastasis and target for therapy. Mol Med. 2015;21:782–791.LinAYanWH.Human leukocyte antigen-G (HLA-G) expression in cancers: Roles in immune evasion, metastasis and target for therapy201521782791Search in Google Scholar
Rouas-Freiss N, Moreau P, LeMaoult J, et al. The dual role of HLA-G in cancer. J Immunol Res. 2014;1–10.Rouas-FreissNMoreauPLeMaoultJThe dual role of HLA-G in cancer2014110Search in Google Scholar
Liu L, Wang L, Zhao L, et al. The role of HLA-G in tumor escape: Manipulating the phenotype and function of immune cells. Front Oncol. 2020;10:1–11.LiuLWangLZhaoLThe role of HLA-G in tumor escape: Manipulating the phenotype and function of immune cells202010111Search in Google Scholar
Paul P, Rouas-Freiss N, Khalil-Daher I, et al. HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA. 1998;95(8):4510–4515.PaulPRouas-FreissNKhalil-DaherIHLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance199895845104515Search in Google Scholar
Derré L, Corvaisier M, Charreau B, et al. Expression and release of HLA-E by melanoma cells and melanocytes: Potential impact on the response of cytotoxic effector cells. J Immunol. 2006; 177(5):3100–3107.DerréLCorvaisierMCharreauBExpression and release of HLA-E by melanoma cells and melanocytes: Potential impact on the response of cytotoxic effector cells2006177531003107Search in Google Scholar
Allard M, Oger R, Vignard V, et al. Serum soluble HLA-E in melanoma: A new potential immune-related marker in cancer. PLoS One. 2011;6:6.AllardMOgerRVignardVSerum soluble HLA-E in melanoma: A new potential immune-related marker in cancer201166Search in Google Scholar
Urosevic M, Dummer R. HLA-G in skin cancer: A wolf in sheep’s clothing? Hum Immunol. 2003; 64(11):1073–1080.UrosevicMDummerR.HLA-G in skin cancer: A wolf in sheep’s clothing?2003641110731080Search in Google Scholar
Urosevic M, Kempf W, Zagrodnik B, et al. HLA-G expression in basal cell carcinomas of the skin recurring after radiotherapy. Clin Exp Dermatol. 2005;30(4):422–425.UrosevicMKempfWZagrodnikBHLA-G expression in basal cell carcinomas of the skin recurring after radiotherapy2005304422425Search in Google Scholar
Zheng J, Xu C, Chu D, et al. Human leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis. Immunol Lett. 2014;161(1):13–19.ZhengJXuCChuDHuman leukocyte antigen G is associated with esophageal squamous cell carcinoma progression and poor prognosis201416111319Search in Google Scholar
Yie SM, Yang H, Ye SR, et al. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma. Am J Clin Pathol. 2007;128(6):1002–1009.YieSMYangHYeSRExpression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma2007128610021009Search in Google Scholar
Julie B, Charles P, Wisnivesky J. Global epidemiology of lung cancer. Ann Glob Heal. 2019;1–16.JulieBCharlesPWisniveskyJ.Global epidemiology of lung cancer2019116Search in Google Scholar
Yazdi MT, van Riet S, van Schadewijk A, et al. The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma. Oncotarget. 2016;7(3):3477–3488.YazdiMTvan RietSvan SchadewijkAThe positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma20167334773488Search in Google Scholar
Llovet J, Kelley R, Villanueva A. Hepatocellular carcinoma. Nat Rev Dis Prim. 2021;7(6):1–28.LlovetJKelleyRVillanuevaA.Hepatocellular carcinoma202176128Search in Google Scholar
Xu Y, Han H, Zhang F. Lesion human leukocyte antigen-F expression is associated with a poor prognosis in patients with hepatocellular carcinoma. Oncol Lett. 2015;9:300–304.XuYHanHZhangF.Lesion human leukocyte antigen-F expression is associated with a poor prognosis in patients with hepatocellular carcinoma20159300304Search in Google Scholar
Crew K, Neugut A. Epidemiology of gastric cancer. World J Gastroenterol. 2006;12(3):354–362.CrewKNeugutA.Epidemiology of gastric cancer2006123354362Search in Google Scholar
Murdaca G, Calamaro P, Lantieri F, et al. HLA-G expression in gastric carcinoma: Clinicopathological correlations and prognostic impact. Virchows Arch. 2018;473(4):425–433.MurdacaGCalamaroPLantieriFHLA-G expression in gastric carcinoma: Clinicopathological correlations and prognostic impact20184734425433Search in Google Scholar
Zeestraten ECM, Reimers MS, Saadatmand S, et al. Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients. Br J Cancer. 2014;110(2):459–468.ZeestratenECMReimersMSSaadatmandSCombined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients20141102459468Search in Google Scholar
Guo ZY, Lv YG, Wang L, et al. Predictive value of HLA-G and HLA-E in the prognosis of colorectal cancer patients. Cell Immunol. 2015;293(1):10–16.GuoZYLvYGWangLPredictive value of HLA-G and HLA-E in the prognosis of colorectal cancer patients201529311016Search in Google Scholar
Ye S, Yang H, Li K. Human leukocyte antigen G expression: As a significant prognostic indicator for patients with colorectal cancer. Mod Pathol. 2007;20:375–383.YeSYangHLiK.Human leukocyte antigen G expression: As a significant prognostic indicator for patients with colorectal cancer200720375383Search in Google Scholar
Breastcancer.org. https://www.breastcancer.org/symptoms/understand_bc/statistics.Breastcancer.orghttps://www.breastcancer.org/symptoms/understand_bc/statistics.Search in Google Scholar
Menier C, Rouas-Freiss N, Favier B, et al. Recent advances on the non-classical major histocompatibility complex class i HLA-G molecule. Tissue Antigens. 2010;75(3):201–206.MenierCRouas-FreissNFavierBRecent advances on the non-classical major histocompatibility complex class i HLA-G molecule2010753201206Search in Google Scholar
de Kruijf EM, Sajet A, van Nes JGH, et al. HLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients. J Immunol. 2010;185(12):7452–7459.de KruijfEMSajetAvan NesJGHHLA-E and HLA-G expression in classical HLA class I-negative tumors is of prognostic value for clinical outcome of early breast cancer patients20101851274527459Search in Google Scholar
Harada A, Ishigami S, Kijima Y, et al. Clinical implication of human leukocyte antigen (HLA)-F expression in breast cancer. Pathol Int. 2015;65(11):569–574.HaradaAIshigamiSKijimaYClinical implication of human leukocyte antigen (HLA)-F expression in breast cancer20156511569574Search in Google Scholar
Gooden M, Lampen M, Jordanova ES, et al. HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8 + T lymphocytes. Proc Natl Acad Sci USA. 2011;108(26):10656–10661.GoodenMLampenMJordanovaESHLA-E expression by gynecological cancers restrains tumor-infiltrating CD8 + T lymphocytes2011108261065610661Search in Google Scholar
Van Esch EMG, Tummers B, Baartmans V, et al. Alterations in classical and nonclassical HLA expression in recurrent and progressive HPV-induced usual vulvar intraepithelial neoplasia and implications for immunotherapy. Int J Cancer. 2014;135(4):830–842.Van EschEMGTummersBBaartmansVAlterations in classical and nonclassical HLA expression in recurrent and progressive HPV-induced usual vulvar intraepithelial neoplasia and implications for immunotherapy20141354830842Search in Google Scholar
Centers for Disease Control and Prevention. Ovarian cancer statistics. https://www.cdc.gov/cancer/ovarian/statistics/.Centers for Disease Control and Preventionhttps://www.cdc.gov/cancer/ovarian/statistics/.Search in Google Scholar
Babay W, Ben Yahia H, Boujelbene N, et al. Clinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma. Hum Immunol. 2018;79(6):463–470.BabayWBen YahiaHBoujelbeneNClinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma2018796463470Search in Google Scholar
Kanevskiy L, Erokhina S, Kobyzeva P, et al. Dimorphism of HLA-E and its disease association. Int J Mol Sci. 2019;20(21):1–16.KanevskiyLErokhinaSKobyzevaPDimorphism of HLA-E and its disease association20192021116Search in Google Scholar
Guan J, Xie L, Luo X. The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: Hormone receptors in risk stratification. Gynecol Oncol. 2019;30(1):1–14.GuanJXieLLuoX.The prognostic significance of estrogen and progesterone receptors in grade I and II endometrioid endometrial adenocarcinoma: Hormone receptors in risk stratification2019301114Search in Google Scholar
Bijen CBM, Bantema-Joppe EJ, De Jong RA, et al. The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer. Int J Cancer. 2010;126(6):1417–1427.BijenCBMBantema-JoppeEJDe JongRAThe prognostic role of classical and nonclassical MHC class I expression in endometrial cancer2010126614171427Search in Google Scholar
Haque A, Banik NL, Ray SK. Molecular alterations in glioblastoma: Potential targets for immunotherapy. Prog Mol Bio and Trans Sci. 2011;98:187–234HaqueABanikNLRaySK.Molecular alterations in glioblastoma: Potential targets for immunotherapy201198187234Search in Google Scholar
Wu Z, Liang J, Wang Z, et al. HLA-E expression in diffuse glioma: Relationship with clinicopathological features and patient survival. BMC Neurol. 2020;20(1):1–7.WuZLiangJWangZHLA-E expression in diffuse glioma: Relationship with clinicopathological features and patient survival202020117Search in Google Scholar
Bukova M, Kluckova K, Kozak J. HLA-G 14 bp ins/del polymorphism, plasma level of soluble HLA-G and association with IL-6/IL-10 ratio and survival of glioma patients. Prepr. 2021;1–23.BukovaMKluckovaKKozakJ.HLA-G 14 bp ins/del polymorphism, plasma level of soluble HLA-G and association with IL-6/IL-10 ratio and survival of glioma patients2021123Search in Google Scholar
Wagner B, Nardi F, Schramm S. HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemia. Wiley Online Libr. 2016;814–823.WagnerBNardiFSchrammS.HLA-E allelic genotype correlates with HLA-E plasma levels and predicts early progression in chronic lymphocytic leukemia2016814823Search in Google Scholar
Nückel H, Rebmann V, Dürig J, et al. HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood. 2005;105(4):1694–1698.NückelHRebmannVDürigJHLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia2005105416941698Search in Google Scholar
Yan WH, Lin A, Chen BG, et al. Unfavourable clinical implications for HLA-G expression in acute myeloid leukaemia. J Cell Mol Med. 2008;12(3):889–898.YanWHLinAChenBGUnfavourable clinical implications for HLA-G expression in acute myeloid leukaemia2008123889898Search in Google Scholar
Sebti Y, Le Maux A, Gros F, et al. Expression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders. Br J Haematol. 2007;138(2):202–212.SebtiYLe MauxAGrosFExpression of functional soluble human leucocyte antigen-G molecules in lymphoproliferative disorders20071382202212Search in Google Scholar
Jesionek-Kupnicka D, Bojo M, Prochorec-Sobieszek M. HLA-G and MHC class II protein expression in diffuse large B-cell lymphoma. Blood. 2016;64(3):225–240.Jesionek-KupnickaDBojoMProchorec-SobieszekM.HLA-G and MHC class II protein expression in diffuse large B-cell lymphoma2016643225240Search in Google Scholar
Diepstra A, Poppema S, Boot M, et al. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin’s lymphoma. Tissue Antigens. 2008;71(3):219–226.DiepstraAPoppemaSBootMHLA-G protein expression as a potential immune escape mechanism in classical Hodgkin’s lymphoma2008713219226Search in Google Scholar
Caocci G, Greco M, Fanni D, et al. HLA-G expression and role in advanced-stage classical Hodgkin lymphoma. Eur J Histochem. 2016;60(2):1–6.CaocciGGrecoMFanniDHLA-G expression and role in advanced-stage classical Hodgkin lymphoma201660216Search in Google Scholar
Martin P, Krsnik I, Navarro B. HLA allele E*01:01 is associated with a reduced risk of EBV-related classical Hodgkin lymphoma independently of HLA-A*01/*02. PLoS One. 2015;1–13.MartinPKrsnikINavarroB.HLA allele E*01:01 is associated with a reduced risk of EBV-related classical Hodgkin lymphoma independently of HLA-A*01/*022015113Search in Google Scholar
Amiot L, Ferrone S, Grosse-Wilde H, et al. Biology of HLA-G in cancer: A candidate molecule for therapeutic intervention? Cell Mol Life Sci. 2011;68(3):417–431.AmiotLFerroneSGrosse-WildeHBiology of HLA-G in cancer: A candidate molecule for therapeutic intervention?2011683417431Search in Google Scholar
Adolf IC, Almars A, Dharsee N, et al. HLA-G and single nucleotide polymorphism (SNP) associations with cancer in African populations: Implications in personal medicine. Genes Dis. 2021;9(5):1220–1233.AdolfICAlmarsADharseeNHLA-G and single nucleotide polymorphism (SNP) associations with cancer in African populations: Implications in personal medicine20219512201233Search in Google Scholar
Belén Palma M, Tronik-Le Roux D, Amín G, et al. HLA-G gene editing: A novel therapeutic alternative in cancer immunotherapy. bioRxiv. 2021. https://doi.org/10.1101/2021.01.21.427294.Belén PalmaMTronik-Le RouxDAmínGHLA-G gene editing: A novel therapeutic alternative in cancer immunotherapy2021https://doi.org/10.1101/2021.01.21.427294.Search in Google Scholar